# Global Asset Fund

> Global Asset Fund is a VC fund in Landshut backing Medical, Therapeutics and Biotechnology. See 8 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Landshut, Germany
- Total investments: 8
- Last investment: Mar 2017
- Lead investor: 13%
- Last updated: Aug 2026
- Website: http://www.global-asset-fund.de

Global Asset Fund is a private equity firm based in Germany that finances early and later stage venture investments. The fund enables the development of products and technologies that address a growing market of tomorrow.

## Round sizes

| Stage | Round size |
| --- | --- |
| Series A | $1M–$1.9M |
| Series B | $1.6M–$2.9M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 13% |
| Therapeutics | 1 | 13% |
| Biotechnology | 1 | 13% |
| Manufacturing | 1 | 13% |
| Semiconductor | 1 | 13% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 1 | 13% |
| Series B | 1 | 13% |
| Funding Round | 1 | 13% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Siltectra | SILTECTRA is a high-tech company specializing in kerfless wafering and thinning, an innovative new technology for manufacturing wafers. Kerfless wafering by SILTECTRA is a platform technology which can be used in a wide variety of industries and for many different materials. | $2.9M | Series B | Mar 23, 2017 |  |
| Siltectra | SILTECTRA is a high-tech company specializing in kerfless wafering and thinning, an innovative new technology for manufacturing wafers. Kerfless wafering by SILTECTRA is a platform technology which can be used in a wide variety of industries and for many different materials. | $1.6M | Series B | Apr 15, 2016 |  |
| Siltectra | SILTECTRA is a high-tech company specializing in kerfless wafering and thinning, an innovative new technology for manufacturing wafers. Kerfless wafering by SILTECTRA is a platform technology which can be used in a wide variety of industries and for many different materials. | $1.6M | Series B | May 15, 2015 |  |
| Siltectra | SILTECTRA is a high-tech company specializing in kerfless wafering and thinning, an innovative new technology for manufacturing wafers. Kerfless wafering by SILTECTRA is a platform technology which can be used in a wide variety of industries and for many different materials. | $1M | Series A | Jun 30, 2014 |  |
| Isarna Therapeutics | Isarna Therapeutics has an unmatched commitment to developing selective TGF-β inhibitors to effectively treat ophthalmic diseases. They are advancing a unique pipeline of novel oligonucleotides and combination modalities to transcend clinical response and improve patient outcomes. | $7.6M |  | Apr 24, 2014 |  |
| Siltectra | SILTECTRA is a high-tech company specializing in kerfless wafering and thinning, an innovative new technology for manufacturing wafers. Kerfless wafering by SILTECTRA is a platform technology which can be used in a wide variety of industries and for many different materials. | $1.9M | Series A | Apr 13, 2013 |  |
| Isarna Therapeutics | Isarna Therapeutics has an unmatched commitment to developing selective TGF-β inhibitors to effectively treat ophthalmic diseases. They are advancing a unique pipeline of novel oligonucleotides and combination modalities to transcend clinical response and improve patient outcomes. | $8.8M |  | Jul 07, 2011 |  |
| Isarna Therapeutics | Isarna Therapeutics has an unmatched commitment to developing selective TGF-β inhibitors to effectively treat ophthalmic diseases. They are advancing a unique pipeline of novel oligonucleotides and combination modalities to transcend clinical response and improve patient outcomes. | $14.3M |  | Mar 15, 2010 |  |

8 of 8 investments shown.

## Co-investors
- [MIG Capital](https://shizune.co/investors/profile/mig-ag) — VC Fund, 8 deals together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [HTGF (High-Tech Gruenderfonds)](https://shizune.co/investors/profile/high-tech-gr%C3%BCnderfonds) — VC Fund
- [HV Capital](https://shizune.co/investors/profile/holtzbrinck-ventures) — VC Fund
- [IBB Ventures](https://shizune.co/investors/profile/ibb) — VC Fund

## Featured in investor lists
- [Biotech Investors in Germany](https://shizune.co/investors/biotech-investors-germany)
- [Biotech VC Funds in Germany](https://shizune.co/investors/biotech-vc-funds-germany)
- [Medical Investors in Germany](https://shizune.co/investors/medical-investors-germany)
- [Biotechnology VC Funds in Germany](https://shizune.co/investors/biotechnology-vc-funds-germany)

## FAQ

### What does Global Asset Fund invest in?

Global Asset Fund invests primarily in Medical, Therapeutics and Biotechnology startups, most often at Series A and Series B stage. Most of the 8 investments tracked by Shizune back companies in Germany. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Global Asset Fund's check size?

Global Asset Fund typically joins rounds of $1M–$1.9M at Series A and $1.6M–$2.9M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Global Asset Fund participates in.

### When did Global Asset Fund last invest?

The most recent investment recorded for Global Asset Fund closed in Mar 2017. Shizune tracks 8 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co